> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Comments Sought on User Fee Waiver Guidance
- URL: https://www.fdaweb.com/comments-sought-on-user-fee-waiver-guidance/
- Published: 2017-05-23T12:00:00.000Z
- Updated: 2026-09-14T22:25:09.000Z
- Author: David McFarland
- Tags: FDA Policy/General, #legacy-id-D5138766

*Federal Register* notice: FDA seeks comments on an information collection extension for its “Guidance for Industry — User Fee Waivers, Reductions, and Refunds for Drug and Biological Products—OMB Control Number 0910–0693.” The notice solicits comments on recommendations to applicants considering whether to request a waiver or reduction in user fees. To view the notice, click [here](https://www.gpo.gov/fdsys/pkg/FR-2017-05-23/pdf/2017-10534.pdf?ref=fdaweb.com).